PPT Slide
The statements in this presentation and oral statements made by representatives of the Company relating to matters that are not historical facts, including, but without limitation, those regarding the timing or potential outcomes of clinical trials and any market that might develop for any of the Company’s product candidates are forward-looking statements that involve risks and uncertainties including, but not limited to, the likelihood that any product in the research pipeline can receive regulatory approval in the United States or abroad, the ability of Emisphere and/or its partners to develop, manufacture and commercialize products using the Company’s drug delivery technology, Emisphere’s ability to fund such efforts with or without partners, and other risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission.